Kimia Biosciences Ltd — Others, 23-07-2025: AGM/EGM

Kimia Biosciences held an Extra-Ordinary General Meeting (EGM) where shareholders considered key resolutions crucial for the company's governance. The agenda included approving the regularization of the Statutory Auditor and an Additional Director. Shareholders actively participated, expressing satisfaction with the company's performance, transparency, and commitment to business continuity. The company facilitated both remote e-voting and e-voting during the meeting. The final voting outcomes for these important proposals will be released to stock exchanges and made available on the company's website upon receipt of the scrutinizer's report, providing clarity on these appointments.